These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16675660)

  • 1. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
    Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
    Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
    Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
    Casanova E; Hernandez AI; Priego EM; Liekens S; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Sep; 49(18):5562-70. PubMed ID: 16942029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
    Liekens S; Bronckaers A; Belleri M; Bugatti A; Sienaert R; Ribatti D; Nico B; Gigante A; Casanova E; Opdenakker G; Pérez-Pérez MJ; Balzarini J; Presta M
    Mol Cancer Ther; 2012 Apr; 11(4):817-29. PubMed ID: 22302099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59).
    Bronckaers A; Aguado L; Negri A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ; Gago F; Liekens S
    Biochem Pharmacol; 2009 Aug; 78(3):231-40. PubMed ID: 19389384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
    Miszczak-Zaborska E; Smolarek M; Bartkowiak J
    Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
    Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
    Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
    Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
    Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of N3-substituted thymine acyclic nucleoside phosphonates and a comparison of their inhibitory effect towards thymidine phosphorylase.
    Pomeisl K; Holý A; Votruba I; Pohl R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1364-7. PubMed ID: 18221873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine phoshorylase as a target for antiangiogenesis treatment.
    Peters GJ; Bijnsdorp IV; Fukushima M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
    Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
    Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
    Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.
    Diab SA; De Schutter C; Muzard M; Plantier-Royon R; Pfund E; Lequeux T
    J Med Chem; 2012 Mar; 55(6):2758-68. PubMed ID: 22372816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
    Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
    An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
    Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
    Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M; Tak J; Chung WY; Park KK
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
    Balzarini J; Gamboa AE; Esnouf R; Liekens S; Neyts J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 1998 Oct; 438(1-2):91-5. PubMed ID: 9821965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.